Publicaciones en las que colabora con FELIPE COUÑAGO LORENZO (32)

2024

  1. Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?

    Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66

  2. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center

    Brachytherapy

  3. Is trimodal therapy the current standard for muscle-invasive bladder cancer?

    Actas Urologicas Espanolas

2023

  1. Jorge clinical study: 10-year outcomes of risk-adapted radiotherapy defined by multiparametric MRI for prostate cancer

    World Journal of Urology, Vol. 41, Núm. 12, pp. 3829-3838

  2. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer

    Oncology (Switzerland), Vol. 101, Núm. 6, pp. 349-357

  3. Oligometastatic Hormone-Sensitive Prostate Cancer. Why Radiotherapy?

    Clinical Genitourinary Cancer, Vol. 21, Núm. 3, pp. e93-e103

  4. PSMA PET/CT imaging for biochemical recurrence of prostate cancer after radiotherapy: is it necessary to review the Phoenix criteria?

    Clinical and Translational Imaging, Vol. 11, Núm. 3, pp. 241-254

  5. Prostate Cancer: Management of Biochemical Recurrence after Surgery

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 733-745

  6. Role of Radiotherapy and Hormone Therapy in Patients with Node-Positive Locally Advanced Prostate Cancer

    Archivos espanoles de urologia, Vol. 76, Núm. 10, pp. 718-732

  7. Total neoadjuvant therapy for locally advanced rectal cancer: a narrative review

    Future oncology (London, England), Vol. 19, Núm. 25, pp. 1753-1768

2022

  1. IJRadiation therapy for recurrent hydatid cyst of the pelvic bone: a case report

    International Journal of Infectious Diseases, Vol. 115, pp. 168-170

2021

  1. Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine

    Breast Disease, Vol. 40, Núm. 1, pp. 1-16

  2. Breast radiotherapy-related cardiotoxicity. When, how, why. risk prevention and control strategies

    Cancers, Vol. 13, Núm. 7

  3. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study

    Journal of Clinical Oncology, Vol. 39, Núm. 28, pp. 3118-3127

2020

  1. Breast radiotherapy in elderly women: Myths, controversies, and current techniques in the adjuvant setting

    Translational Cancer Research, Vol. 9, pp. S37-S55

  2. Clinical applications of molecular biomarkers in prostate cancer

    Cancers, Vol. 12, Núm. 6, pp. 1-25

  3. High-dose neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery in potentially-resectable stage IIIA-N2 NSCLC. A multi-institutional retrospective study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 447-455

  4. Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain

    Reports of Practical Oncology and Radiotherapy, Vol. 25, Núm. 3, pp. 405-411

2019

  1. Management of oligometastatic non-small cell lung cancer patients: Current controversies and future directions

    WORLD JOURNAL OF CLINICAL ONCOLOGY, Vol. 10, Núm. 10, pp. 318-339

  2. Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer

    Reports of Practical Oncology and Radiotherapy, Vol. 24, Núm. 5, pp. 472-480